Osaic Holdings
RNAC icon

Osaic Holdings’s Cartesian Therapeutics RNAC Stock Holding History

Osaic Holdings’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15K Hold
302
– – ﹤0.01% 7121
2026
Q1 		$1.85K Buy
302
+195
+182% +$1.39K ﹤0.01% 7066
2025
Q4 		$770 Sell
107
-197
-65% -$1.59K ﹤0.01% 7337
2025
Q3 		$3.09K Hold
304
– – ﹤0.01% 6986
2025
Q2 		$3.16K Buy
304
+200
+192% +$2.13K ﹤0.01% 6775
2025
Q1 		$1.37K Sell
104
-66
-39% -$1.18K ﹤0.01% 6720
2024
Q4 		$3.04K Sell
170
-64
-27% -$1.3K ﹤0.01% 6441
2024
Q3 		$3.77K Sell
234
-62
-21% -$969 ﹤0.01% 6339
2024
Q2 		$6.35K Buy
296
+58
+24% +$1.38K ﹤0.01% 6049
2024
Q1 		$4.64K Sell
238
-64
-21% -$1.36K ﹤0.01% 6119
2023
Q4 		$6.25K Buy
302
+16
+6% +$478 ﹤0.01% 6067
2023
Q3 		$9.1K Buy
286
+25
+10% +$835 ﹤0.01% 5966
2023
Q2 		$8.77K Sell
261
-167
-39% -$5.98K ﹤0.01% 6037
2023
Q1 		$17.8K Buy
428
+33
+8% +$1.55K ﹤0.01% 5633
2022
Q4 		$14.2K Buy
395
+73
+23% +$3.11K ﹤0.01% 5759
2022
Q3 		$16K Sell
322
-1,129
-78% -$62K ﹤0.01% 5756
2022
Q2 		$57K Buy
1,451
+1,334
+1,140% +$39.6K ﹤0.01% 4859
2022
Q1 		$5K Hold
117
– – ﹤0.01% 6498
2021
Q4 		$12K Hold
117
– – ﹤0.01% 6147
2021
Q3 		$14K Hold
117
– – ﹤0.01% 6022
2021
Q2 		$15K Buy
117
+111
+1,850% +$13.2K ﹤0.01% 5832
2021
Q1 		$1K Buy
+6
New +$745 ﹤0.01% 6686
2020
Q3 		– Sell
-3
Closed – – 6378
2020
Q2 		$0 Buy
+3
New +$272 ﹤0.01% 6291

Other funds holding RNAC

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings's RNAC Position: Q2 2026 in Review

Osaic Holdings held its Cartesian Therapeutics (RNAC) position steady in Q2 2026 at 302 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #7121.

Osaic Holdings first reported a position in RNAC in Q2 2020 and has held it in 23 quarters since. The position peaked at $57K in Q2 2022. 94 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • Osaic Holdings held 302 shares of Cartesian Therapeutics worth $3.15K as of Q2 2026.
  • Osaic Holdings left its Cartesian Therapeutics share count unchanged in Q2 2026.
  • Cartesian Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7121 holding.
  • Osaic Holdings first reported a position in Cartesian Therapeutics in Q2 2020 and has held it in 23 quarters since.
  • Osaic Holdings's Cartesian Therapeutics position peaked at $57K in Q2 2022.
  • 94 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.